RNase inhibitor (Recombinant) CAS UENA-0193


CAS Number


EC Number


RNase inhibitor (Recombinant)


Definition of active unit

Definition of active unit: 1 active unit is defined as the amount of enzyme needed to inhibit 50% of RNase A activity (RNase A activity is determined by inhibiting its hydrolysis of cytidine 2′ and 3′-cyclic monophosphate.).

Safety Data


NONH for all modes of transport

WGK Germany


Specifications and Other Information of Our RNase inhibitor (Recombinant) CAS UENA-0193

Product Introduction

This product is the murine RNase inhibitor recombinantly expressed in E. coli. It binds to RNase to form a complex, thereby inhibiting RNase activity and protecting target RNA from degradation.

Product Features

Efficient inhibition of the activity of RNase A, RNase B and RNase C, no nuclease contamination, no residual microbial-derived DNA. Improving the yield of all RNA experiment products and the mRNA integrity of IVT products. Suitable for almost all experiments sensitive to RNA integrity.

Product Features

Product Composition

Item No.CompositionStorage Temperature
(℃ )
IRNase Inhibitor (Recombinant) (40 U/μL)-200.5mL5mL

Quality Control

Purity ≥ 95%, residual host cell DNA ≤ 100pg/mg, residual host cell protein ≤ 50ppm, residual endotoxin ≤10EU/mg, no residual RNase, endonuclease, exonuclease or protease, germ-free, pathogen-free.

This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).